In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

High Risk Medicines Survey 2020/21


High Risk Medicines Scheme – Quarter 4 2020/21

 
Contractors will be aware that in March 2020 the Quality & Safety Scheme was suspended until further notice, contractors were informed in the contractor events in November and through the newsletter that to meet the requirements of the Quality & Safety Scheme for Quarter 4 of 2020-21 they were required to complete:
  • AWPD validation (carried out in November/ December 2020)
  • Completion of High Risk Medicines prevalence data on Valproate dispensing

Welsh Government have now provided CPW with the information in respect of the data required:
 
The pharmacy will provide information on the number of patients whose prescriptions were dispensed in the pharmacy during March 2021 where the following conditions are met:
 
  1. Use of valproate in girls and women of childbearing potential
 
1.1. Dispensed a prescription for sodium valproate or valproic acid
 
AND
 
1.2. Who are female
 
AND
 
  1.    Who are aged between 13 and 45
 
Of the patients identified in 1, the number who participate in the Valproate Pregnancy Prevention Programme.  Details of the PPP are available at https://www.gov.uk/drug-safety-update/valproate-pregnancy-prevention-programme-actions-required-now-from-gps-specialists-and-dispensers